Navigation Links
Test for hormones in blood not reflective of hormones in breast tissue; breast cancer risk
Date:4/22/2009

Denver, Colo. Many studies determine hormone levels in the blood as a marker of breast cancer risk. But it hasn't been known whether these blood tests reflect what is happening in the breast tissue, where certain hormones fuel cancer. Researchers at Georgetown University Medical Center's (GUMC) Lombardi Comprehensive Cancer Center found that measuring the levels of four hormones in blood known to be linked to breast cancer doesn't necessarily reflect the levels of these hormones in the breast tissue itself.

In fact, the scientists say that blood tests used in research studies that measure these hormones could give a false impression of both the real breast cancer risk women face, and an imprecise picture of how these hormones affect breast cancer development. The findings are being presented at the Annual Meeting of the American Association for Cancer Research.

"We know from this study that measuring the hormones in a patient's blood is not sufficient but that is how many research studies looking at breast cancer risk are being conducted," says the study's lead author, Adana Llanos, a graduate student in genetics at GUMC. "Understanding how cancers develop in breast tissue is the key to prevention, and we need to understand how these hormones affect breast tissue."

The research team, led by Llanos and under the guidance of senior investigator, Peter G. Shields, MD, head of Lombardi's Cancer Genetics and Epidemiology Program, did something that has not been done before: They tested normal breast tissue for the levels of IGF-1, IGFBP-3, adiponectin, and leptin. High levels of IGF-1 has been linked to breast cancer development, while low levels of IGFBP-3 is linked to increased risk. High levels of adiponectin and leptin are both related to obesity, which is, in itself, a risk factor for breast cancer.

"By understanding these hormones in the normal breast environment, we will have some insight into how early changes in th
'/>"/>

Contact: Karen Mallet
km463@georgetown.edu
215-514-9751
Georgetown University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Organic Left Standing as the Gold Standard for Consumers Looking to Avoid Food Produced With Synthetic Growth Hormones
2. Hormones May Help Shield Women from Parkinsons
3. Findings raise new questions about evolution of hormones in mammals
4. Female Hormones Deter Salt-Sensitive Hypertension
5. Tweaking Hormones Might Ease Chronic Stress
6. Newly Released Book by Retired Scientist Links Self-Control of Hormones to Perfecting One's Life
7. Erika Schwartz MD Congratulates Oprah Winfrey for Spotlighting Bioidentical Hormones
8. Susan Lark, MD Continues to Urge Women to Fight for Their Right to Use Bioidentical Hormones
9. Susan Lark, MD Urges Women to Fight for Their Right to Use Bioidentical Hormones
10. Women Using Compounded Bioidentical Hormones Miss the Full Story About These Drugs
11. Vigorous Treadmill Workout Curbs Appetite Hormones

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...erm survivors of testicular cancer who were treate...e side effects, including neurological side effect...t treated with chemotherapy, according to a new st...f the National Cancer Institute . , Marianne Bry... University Hospital, in Bergen, Norway, and colle...
(Date:11/25/2009)...b, already used to fight rheumatoid arthritis, cou... , WEDNESDAY, Nov. 25 (HealthDay News) -- ...ma and rheumatoid arthritis now also shows some pr...e 1 diabetes. , The drug, rituximab (Rituxan), ...nsulin, even though the disease had destroyed some...
(Date:11/25/2009)...NEWYORK,Nov.25/PRNewswire/-- MISSIONSkincare ®...ionforSt.Jude.AspartofGNC,sannualSt.Jude Thanksand...IONSkincare,s new SUPER-C(TM)LipBalm willbedonat...unitytomakea$1,$5or$10donationatcheckoutatoneofthe...morethan$1millionforSt.Judeduringtheir2009 Thanksa...
(Date:11/25/2009)...rious behavior problems that can occur in children... with a treatment plan that includes medication co...nts, according to Yale University researchers and ...009 issue of the Journal of the American Academy ... conducted by the National Institute of Mental Hea...
(Date:11/25/2009)... BioSpace.com, the premier resour...led the third edition of the BioForest™ Hotb... Englewood, CO (Vocus) November 25, 2009 -- BioS...reers and information, unveiled the third edition ...ng., , , , ,This regional campaign is a promotion...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
...ime Emmy,nominated actress Colleen Zenk Pinter, be... on CBS,s As the World Turns, has teamed up with t...r battle against oral cancer, and,raise public awa...030 ), Zenk Pinter,s first stop was CBS,s The Ea...
...Inc.,(CTI) (Nasdaq: CTIC ; MTAX) today announced ...imately $6.5 million of its 7% Convertible,Preferr...several,institutional investors, including certain...r share of Series D,convertible preferred stock. T...
...nsylvania Public,Utility Commission (PUC) approved...e case., The settlement, which was reached among ...he Office of Consumer Advocate, Office of Small,Bu...charge that customers have already been paying rel...
...tionally, clinicians have relied on information pr...ts as the primary means of assessing patients symp...s consequences could arise if important symptoms g...C) finds that even the sickest cancer patients are...
...izing their Animals and Homes, SACRAMENTO, Calif....are enough to shelter them from the cold. But acco...tion (CVMA), pets can be extremely,vulnerable in t... vary in size, age, and health status, you need to...
...as,treating in the Yale University-affiliated comm...Garth Graham thought he could almost be looking in... age, and lived near,Graham,s own home in New Have... and losing weight for no apparent reason. When Gr...
Other Medicine News:Health News:Actress Colleen Zenk Pinter Partners with the Oral Cancer Foundation to Raise Public Awareness 2Health News:Actress Colleen Zenk Pinter Partners with the Oral Cancer Foundation to Raise Public Awareness 3Health News:Cell Therapeutics, Inc. Announces $6.5 Million Offering 2Health News:Cell Therapeutics, Inc. Announces $6.5 Million Offering 3Health News:Pennsylvania American Water's Rate Case Approved 2Health News:Pennsylvania American Water's Rate Case Approved 3Health News:Cancer patients may benefit from reporting symptoms online in real time 2Health News:Cancer patients may benefit from reporting symptoms online in real time 3Health News:Cancer patients may benefit from reporting symptoms online in real time 4Health News:Protect Pets From Winter's Hidden Dangers 2Health News:Protect Pets From Winter's Hidden Dangers 3Health News:Take the Test, Take Control: World AIDS Day 2007 2
(Date:11/24/2009)...,, IRVINE,Calif.,Nov.24/PRNewswire-FirstCall...llyinvasivetreatmentsforaorticdisorders,announcedt...oceedingsin,thepatentinfringementlawsuitbroughtaga...heUnitedStatesDistrictCourtinIndianapolis,Indiana....ectwhiletheUnitedStatesPatentandTrademarkOffice(US...
(Date:11/24/2009)...,, WOODCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNew...heU.S.FoodandDrugAdministration(FDA)hasacceptedfor...mgAricept®(donepezilHClextendedrelease)tablet...se(AD).Thisnewhigherdoseformulationcontains23mgofd...thadeliverysystemthatallowsforgradualreleaseofthed...
(Date:11/24/2009)...,, STAMFORD,Conn.,Nov.24/PRNewswire/--Zargis...E )andaspin-offfromSiemensCorporateResearch(NYSE: ...sfeaturedontheNovember24,2009episodeofCBS, TheEarl...PopularScience magazine,reviewedfivewinningproduct...,, TheEarlyShow isawidely-viewedtelevisionmorn...
Breaking Medicine Technology:Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Arcadia Resources Announces Webcast of its Fiscal 2009 Fourth Quarter and Year End Conference Call 48847 1Arcadia Resources Announces Webcast of its Fiscal 2009 Fourth Quarter and Year End Conference Call 48847 2Forterus Inc Treatment Centers Serving Middle Class 3B Rapid Growth Detailed in Paul Howarth Interview 48844 1Forterus Inc Treatment Centers Serving Middle Class 3B Rapid Growth Detailed in Paul Howarth Interview 48844 2Parents In Wisconsin Can Now Test Their Children For Lead Exposure Using Saliva 48843 1Parents In Wisconsin Can Now Test Their Children For Lead Exposure Using Saliva 48843 2Parents In Wisconsin Can Now Test Their Children For Lead Exposure Using Saliva 48843 3Parents In Wisconsin Can Now Test Their Children For Lead Exposure Using Saliva 48843 4
...INESS WIRE)--Apr 16, 2007 - Amgen,(Nasdaq:AMGN) to...e-blind, placebo-controlled Phase 3 study evaluati...tin alfa) for the,treatment of anemia in patients ...adiotherapy ("the 103 study"). Aranesp is not,appr... These,results were presented in an oral session a...
...primary endpoint not met; plausibly,confounded by ...TUX,-, NEW YORK, April 16, 2007 /PRNewswire-FirstC...yers Squibb Company today,announced detailed resul... multi-center Phase III trial - comparing ERBITUX(... in patients with,metastatic colorectal cancer (mC...
Other Medicine Technology:Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 2Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 5Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 6Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9
Sophia Vest V-654
Gabrielle Vest V-650
Female Mini-VEST, Front Closure, X-Firm
Male Support Brief
Medicine Products: